M A Mohammed
Overview
Explore the profile of M A Mohammed including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mohammed M, Al-Aziz S, Al Sumati E, Mahmoud E
Comput Intell Neurosci
. 2022 May;
2022:4822212.
PMID: 35535185
The LINEX loss function, which climbs exponentially with one-half of zero and virtually linearly on either side of zero, is employed to analyze parameter analysis and prediction problems. It can...
2.
Mohammed M, Alshanbari H, El-Bagoury A
Comput Intell Neurosci
. 2022 Mar;
2022:2307911.
PMID: 35321454
For a variety of well-known approaches, optimum predictors and estimators are determined in relation to the asymmetrical LINEX loss function. The applications of an iteratively practicable lowest mean squared error...
3.
Mahmoud R, Mohammed M, Said E, Morsi E, Abdelaleem O, Abdel All M, et al.
Eur Rev Med Pharmacol Sci
. 2022 Feb;
26(2):345.
PMID: 35113407
Correction to: European Review for Medical and Pharmacological Sciences 2021; 25 (19): 6013-6024-DOI: 10.26355/eurrev_202110_26879-PMID: 34661261, published online on 15 October 2021. After publication, the authors applied to add some corrections...
4.
Mahmoud R, Mohammed M, Said E, Morsi E, Abdelaleem O, Abdel All M, et al.
Eur Rev Med Pharmacol Sci
. 2021 Oct;
25(19):6013-6024.
PMID: 34661261
Objective: Methotrexate (MTX) is one of the most commonly used anti-cancer drugs for various types of neoplasms. It is associated with multiple cytotoxic effects including nephrotoxicity, hepatotoxicity and cardiotoxicity. Liraglutide...
5.
Yimer N, Mohammed M, Solomon K, Tadese M, Grutzmacher S, Meikena H, et al.
Public Health
. 2021 Jun;
195:105-111.
PMID: 34082174
Objectives: The objective of this study is to estimate the pooled uptake of cervical cancer screening and identify its predictors in Sub-Saharan Africa. Study Design: Systematic review and meta-analysis. Methods:...
6.
Nagy L, Horne M, Faisal M, Mohammed M, Barber S
BMC Public Health
. 2019 Feb;
19(1):152.
PMID: 30717718
Background: Sedentary behaviour (SB) in childhood is a major public health concern. Little is known about ethnic differences in SB during school and holiday weeks among White British (WB) and...
7.
Mohammed M, Aboulhoda B, Mahmoud R
Hum Exp Toxicol
. 2018 Nov;
38(3):321-335.
PMID: 30458643
Background: Despite being one of the most nephrotoxic drugs, gentamicin (GM) remains a mainstay as a first-choice agent in a vast variety of clinical situations owing to its superlative efficiency...
8.
Muhammad M, El-Taalu A, Mohammed M, Yarube I, Nuhu J, Yusuf I, et al.
Niger J Physiol Sci
. 2018 Aug;
33(1):1-8.
PMID: 30091726
Caffeine is known to confer neuro-protection via A1 and A2A adenosine receptor antagonism in which adenosine neuro-modulates excitotoxic release of glutamate. Currently, it is unclear whether caffeine modulates inflammation in...
9.
Faisal M, Howes R, Steyerberg E, Richardson D, Mohammed M
QJM
. 2016 Aug;
110(1):27-31.
PMID: 27486263
Background: The Biochemistry and Haematology Outcome Model (BHOM) relies on the results from routine index blood tests to predict the patient risk of death. We aimed to externally validate the...
10.
Ward S, Hancox A, Mohammed M, Ismail T, Griffiths E, Valori R, et al.
Gut
. 2016 Mar;
66(6):1022-1033.
PMID: 26976733
Objective: The aim of this study was to determine the number of OGDs (oesophago-gastro-duodenoscopies) trainees need to perform to acquire competency in terms of successful unassisted completion to the second...